MedPath

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

Phase 3
Completed
Conditions
HIV Infections
Registration Number
NCT00002208
Lead Sponsor
Merck Sharp & Dohme LLC
Brief Summary

To demonstrate that the antiviral activity and safety/tolerability of a test regimen of indinavir is equivalent to that of a control regimen of indinavir when each is coadministered with zidovudine (ZDV) (or stavudine, d4T) and lamivudine (3TC) for 24 weeks to protease inhibitor- and 3TC-naive HIV-1-seropositive patients. To characterize the steady-state pharmacokinetic profiles of indinavir, ZDV (or d4T), and 3TC in the presence of each other, for both the control and test regimen groups.

Detailed Description

Patients are randomized to 1 of 2 arms:

Arm A: Indinavir plus ZDV plus 3TC. Arm B: Indinavir (test dose) plus ZDV plus 3TC. NOTE: d4T may be substituted for zidovudine for toxicity management. Patients are stratified based on prior use of nucleoside analogs (naive vs experienced to ZDV, dideoxyinosine \[ddI\], dideoxycytidine \[ddC\], and d4T) and screening viral RNA results (lower than 50,000 copies/mL vs more than 50,000 copies/mL).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (15)

Univ of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

LAC/USC Med Ctr

🇺🇸

Los Angeles, California, United States

Kaiser Med Ctr

🇺🇸

San Francisco, California, United States

Wilmington Hosp / Med Ctr of Delaware

🇺🇸

Wilmington, Delaware, United States

Georgetown Univ Med Ctr

🇺🇸

Washington, District of Columbia, United States

AIDS Research Consortium of Atlanta

🇺🇸

Atlanta, Georgia, United States

Cook County Hosp

🇺🇸

Chicago, Illinois, United States

Johns Hopkins Hosp

🇺🇸

Baltimore, Maryland, United States

Washington Univ

🇺🇸

St. Louis, Missouri, United States

Univ Hosp / SUNY at Stony Brook / AIDS TMT Unit

🇺🇸

Stony Brook, New York, United States

Scroll for more (5 remaining)
Univ of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.